Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Hopes MMH delisting will help rail line get built
Infrastructure

Hopes MMH delisting will help rail line get built

Crawford says a rail link to Northport is crucial for the port's growth.

Dileepa Fonseka 30 May 2025
Govt announces 'farmer-focused' RMA reforms
Primary Sector

Govt announces 'farmer-focused' RMA reforms

Proposed reforms cover freshwater, farming practice, mining and quarrying.

Pattrick Smellie 29 May 2025
Govt shifting consent priorities towards development
Policy

Govt shifting consent priorities towards development

The Government said it was releasing three discussion documents on the changes.

Oliver Lewis 29 May 2025